(Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
The AIM-traded firm said that since its recapitalisation in August, it had undergone a cost reduction initiative, streamlining production processes to boost capacity, and decreased material requirements from customers.
It also continued to expand and convert its commercial pipeline, with a recent partnership involving a genetic medicines company to advance Optimer development, facilitating targeted delivery of new medicines.
At 1121 GMT, shares in Aptamer Group were down 2.5% at 1.17p.
Reporting by Josh White for Sharecast.com.


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.


(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...


Aptamer Group PLC - York, England-based synthetic binders developer - Strikes licensing agreement with Alphazyme Inc. This grants Jupiter, Florida-bas...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...


(Sharecast News) - Aptamer Group said in an update on Thursday that it entered its new financial year with growing commercial momentum and increased v...


(Sharecast News) - Aptamer Group said on Friday that two new pharmaceutical contracts worth £0.19m had lifted its binding 2026 order book to ...


(Alliance News) - Aptamer Group PLC on Friday announced new contracts as it expects annual revenue to further grow.


(Sharecast News) - Aptamer Group announced on Tuesday that it has signed a new contract worth up to £0.62m with a top five global pharmaceutical ...


Aptamer Group PLC - York, England-based synthetic binders developer - Wins new contract with a "top five pharmaceutical company" with a value of up to...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.